Recent News

Latest GeoVax News

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
328
Elicitation of a Key Precursor forBroadly Neutralizing Antibody for the HIV CD4 Binding Site GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today...
Last modified on Continue reading
175
Presentations Will Focus on the Broad Utility of GeoVax’s Vaccine PlatformAgainst Emerging Infectious Diseases and Cancer GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
Last modified on Continue reading
168
Presentation Will Focus on GeoVax’s Development of Vaccines AgainstEmerging Infectious Diseases such as Zika, Ebola and Lassa Fever GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
Last modified on Continue reading
458
Presentation Made During 11th Vaccine Congress in San Diego GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced that its Chief Scientific Officer,...
Last modified on Continue reading
527
Vaccine Based on Zika NS1 Protein Achieved 100% Protection in Lethal Challenge Model with a Single Immunization GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing...
Last modified on Continue reading